nanobiose reliable and more predictive evaluation

Innovative tools for
in vitro evaluation

Lab on a chip combining 3D cell culture
real-time capture of secreted biomarkers

nanobiose immunotoxicity of nanoparticles

Immunological Safety

Solutions to assess the impact of
innovative healthcare products



Immunotoxicology Services
From in vitro assay to regulatory support

Why Nanobiose

90% of drug candidates selected in the preclinical phases fail in the clinical assays on Man, mainly for efficacy or safety issues which have not been previously detected. This has a huge economic impact on the pharmaceutical / biotech companies but also on patients, who are waiting for the innovative treatments they need.

This huge attrition rate indicates a lack of efficient tools at the early stages of development to evaluate correctly their new molecules, when researchers and developers must take strategic “go / no go” decisions about their projects.

What We Offer

To help researchers to evaluate better their news drugs at early stages, Nanobiose created SecretCells®, a  disposable lab-on-a-chip which combines 3D cell culture capacities to better mimic in-vivo like conditions with the simultaneous real-time capture of up to 9 secreted biomarkers.

Who We Are

Nanobiose is a specialized company founded in july 2016 near Chambéry (France), at the alpine crossroads of Europe. Nanobiose is developing innovative lab-on-a-chip solutions for improved in vitro evaluation of the activity/safety of new molecular entities at an early stage ranging from:

  • Pharmaceuticals, Biopharmaceuticals
  • Nanomedicines, Nanovectors, Vaccines
  • Innovative dermocosmetics
  • Active ingredients
  • Implants

Our Partners